Latest Breaking News On - Department of neurosciences - Page 29 : vimarsana.com

DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Host Virtual Event on Current Clinical Landscape in Alzheimer's Disease Treatment Options with Leaders and Experts on April 15th, 2021

DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Host Virtual Event on Current Clinical Landscape in Alzheimer's Disease Treatment Options with Leaders and Experts on April 15th, 2021

New drug prevents hallmark of Alzheimer's disease in animals

New drug prevents hallmark of Alzheimer’s disease in animals Written by Timothy Huzar on March 9, 2021 — Fact checked by Hannah Flynn, MS Alzheimer’s disease affects more than 5 million people in the United States. There is currently no cure. A hallmark of Alzheimer’s is the formation of so-called plaques, which affect the functioning of cells in the brain. In a recent series of studies in animals, scientists have shown that a drug that modulates the behavior of one enzyme reduces the formation of plaques. Scientists have identified a new drug that is effective at inhibiting the development of plaques, a key sign of Alzheimer’s disease, in the brains of animals.

Novel Drug Prevents Amyloid Plaques, a Hallmark of Alzheimer's Disease

Alzheimer's Disease: Drug Prevents Amyloid Plaques in Animal Models

In a new study, researchers report that they have identified a new drug that could prevent Alzheimer's disease by modulating, rather than inhibiting, a key enzyme involved in the formation of amyloid plaques.